ADVENT THERAPEUTICS
Advent Therapeutics is focused on providing therapies for micro-orphan applications. The company is based in Lumberville, Pennsylvania.
ADVENT THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2014-01-01
Address:
Lumberville, Pennsylvania, United States
Country:
United States
Website Url:
http://www.advent-therapeutics.com
Total Employee:
1+
Status:
Active
Total Funding:
3.05 M USD
Similar Organizations
D2M Biotherapeutics
D2M Biotherapeutics focuses on the development of novel immunotherapeutics.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Current Employees Featured
Founder
Investors List
National Institutes of Health
National Institutes of Health investment in Grant - Advent Therapeutics
Ben Franklin Technology Partners
Ben Franklin Technology Partners investment in Grant - Advent Therapeutics
Ben Franklin Technology Partners of Southeastern Pennsylvania
Ben Franklin Technology Partners of Southeastern Pennsylvania investment in Seed Round - Advent Therapeutics
Official Site Inspections
http://www.advent-therapeutics.com Semrush global rank: 6.38 M Semrush visits lastest month: 1.05 K
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Advent Therapeutics"
Advent Therapeutics - Crunchbase Company Profile & Funding
Organization. Advent Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Advent Therapeutics is focused on …See details»
Advent Therapeutics Company Profile 2024: Valuation, …
Advent Therapeutics has raised $420K. Who are Advent Therapeutics’s investors? National Center For Advancing Translational Sciences, U.S. Department of Health and Human Services, and Ben Franklin Technology …See details»
Advent Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Advent Therapeutics, Inc. of Lumberville, PA. Get the latest business insights from Dun & Bradstreet.See details»
Advent Therapeutics, Inc. | Lumberville, Bucks County, …
May 1, 2014 Advent Therapeutics, Inc. Ben Franklin provides support for our therapy for neonatal Bronchopulmonary Dysplasia, a serious disorder afflicting premature infants, to …See details»
Advent Therapeutics - VentureRadar
Advent Therapeutics is a late-stage neonatology and rare disease biopharmaceutical company pioneering life-changing medicines for extremely preterm infants. We are focused on …See details»
Advent Therapeutics - Funding, Financials, Valuation & Investors
Advent Therapeutics is focused on providing therapies for micro-orphan applications. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. ...See details»
Advent Therapeutics Awarded $3 Million NIH Grant for Novel …
Jul 18, 2023 Expedites Development of Non-Invasive Inhaled Bronchopulmonary Dysplasia TherapyDOYLESTOWN, Pa., July 18, 2023 (GLOBE NEWSWIRE) -- Advent Therapeutics, …See details»
Advent receives NIH grant for bronchopulmonary …
Jul 19, 2023 Advent Therapeutics CEO David Lopez stated: “This NIH award will allow us to greatly accelerate the development and advance towards approval of our optimised vitamin A drug product. “Advent’s novel, precisely optimised …See details»
Advent Therapeutics Receives FDA Rare Pediatric Disease …
DOYLESTOWN, Pa., July 20, 2023 (GLOBE NEWSWIRE) -- Advent Therapeutics, Inc., a late-stage biotechnology company developing precisely optimized retinol palmitate (vitamin A) drug …See details»
Advent Therapeutics Awarded $3 Million NIH Grant for Novel
Jul 18, 2023 Advent Therapeutics, Inc. (Advent) was founded by senior industry executives with extensive expertise and proven track records in developing products in respiratory diseases …See details»
Firm | SBIR
Advent Therapeutics is a company that develops new therapies for neonatal, pediatric, and Orphan Drug “niche” markets to address serious unmet medical needs. Our team proposes …See details»
News - Advent Therapeutics
Jul 18, 2023 Advent Therapeutics awarded $3 million NIH grant for novel neonatal lung therapy - expedites development of non-invasive inhaled bronchopulmonary dysplasia therapy. In The …See details»
Advent Therapeutics Awarded $3 Million NIH Grant For Novel …
Jul 20, 2023 Advent Therapeutics, Inc., a biotechnology company pioneering an optimized retinol palmitate (vitamin A) drug product as a breakthrough non-invasive inhaled neonatal …See details»
Advent Therapeutics - Contacts, Employees, Board Members
Organization. Advent Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. …See details»
Robert Segal - Chief Medical Officer-Cofounder
Feel free to reach me at 267-237-7576 or [email protected]. · Experience: Advent Therapeutics, Inc. · Education: UCLA · Location: United States · 122 connections on LinkedIn.See details»
Aerosolized vitamin A impact on lung maturation and hyperoxic …
Jul 1, 2018 Advent Therapeutics Inc. (Advent) is a biotech company focusing on the development, reformulation and optimized delivery of legacy drugs to address serious unmet …See details»
Advent Therapeutics - Tech Stack, Apps, Patents & Trademarks
Advent Therapeutics is actively using 3 technologies for its website, according to BuiltWith. These include Google , Google Cloud , and Wix . Website Tech Stack by BuiltWithSee details»
Baxter Signs Definitive Agreement to Divest its BioPharma …
May 8, 2023 PDF . DEERFIELD Ill. and BOSTON and NEW YORK - 2023-05-08 Baxter International Inc. (NYSE:BAX), a leading global medtech company, today announced that it …See details»
Pipeline-vitMIN A - Advent Therapeutics
Vitamin A plays a key role in multiple metabolic, development and reparative pathways including alveologenesis (late-stage lung development) and other organs, mitigates lung injury, …See details»